GLOBAL DATABASE
| Companies recently added(a) updated(u): | Database Listed: 7504 | Nov 23, 2009 | Time: 04:23 | |||
| 11:26 u | ||||||
| 13:11 u | ||||||
| 09:46 u | ||||||
| 09:26 u | ||||||
| 10:33 u | ||||||
CUTTING EDGE COMPANIES IN THE NEWS
|
| November 22, 2009 |
[Company Profile] Pico-Tesla Magnetic Therapies |
|
| November 19, 2009 |
Echo Therapeutics: Positive Developments for Needle-Free Monitoring System |
|
| November 15, 2009 |
Burrill Report: Biotech Innovation Gets the Cash |
| ImmunoGen Signs 2nd Licensing Deal with AmgenImmunoGen has licensed its anti-cancer technology to Amgen for an upfront payment of $1 million. |
| Controversy Over New Breast Cancer Screening GuidelinesThe U.S. Preventive Services Task Force recommended this week that women should begin getting routine mammograms at the age of 50 instead of the previously recommended age of 40. |
| Spherix Shares Rise on Promising Diabetes Drug DataShares in Spherix shot up by 77 percent after the biotechnology company announced preliminary Phase III results for its Type 2 diabetes drug candidate. |
| Adeona’s Experimental RA Drug Does Well in Phase II TrialAdeona Pharmaceuticals, a developer of medications for CNS and autoimmune diseases, announced data from a Phase II clinical trial of its rheumatoid arthritis drug candidate. |
| Ironwood Receives $75M from Astellas for IBS DrugThe Cambridge, Mass.-based company has signed a $75 million deal with Astella Pharmaceuticals to market Ironwood’s IBS drug in Asia. |
| Avanir Shares Rise on Zenvia Trial DataAvanir, a pharmaceutical company developing treatments for CNS disorders and inflammatory diseases, announced that its multiple sclerosis drug Zenvia met its goal in a six-month clinical trial. |
| Bioniche Receives $6M Milestone Payment for Bladder Cancer DrugBioniche Life Sciences has received its first milestone payment of $6 million from Endo Pharmaceuticals for its experimental bladder cancer drug. |




























